UNLABELLED: Postsynaptic N-methyl-d-aspartate receptors (NMDARs) phasically activated by presynaptically released glutamate are critical for synaptic transmission and plasticity. However, under pathological conditions, excessive activation of NMDARs by tonically increased ambient glutamate contributes to excitotoxicity associated with various acute and chronic neurological disorders. Here, using heterologously expressed GluN1/GluN2A and GluN1/GluN2B receptors and rat autaptic hippocampal microisland cultures, we show that pregnanolone sulfate inhibits NMDAR currents induced by a prolonged glutamate application with a higher potency than the NMDAR component of EPSCs. For synthetic pregnanolone derivatives substituted with a carboxylic acid moiety at the end of an aliphatic chain of varying length and attached to the steroid skeleton at C3, the difference in potency between tonic and phasic inhibition increased with the length of the residue. The steroid with the longest substituent, pregnanolone hemipimelate, had no effect on phasically activated receptors while inhibiting tonically activated receptors. In behavioral tests, pregnanolone hemipimelate showed neuroprotective activity without psychomimetic symptoms. These results provide insight into the influence of steroids on neuronal function and stress their potential use in the development of novel therapeutics with neuroprotective action. SIGNIFICANCE STATEMENT: Synaptic activation of N-methyl-d-aspartate receptors (NMDARs) plays a key role in synaptic plasticity, but excessive tonic NMDAR activation mediates excitotoxicity associated with many neurological disorders. Therefore, there is much interest in pharmacological agents capable of selectively blocking tonically activated NMDARs while leaving synaptically activated NMDARs intact. Here, we show that an endogenous neurosteroid pregnanolone sulfate is more potent at inhibiting tonically than synaptically activated NMDARs. Further, we report that a novel synthetic analog of pregnanolone sulfate, pregnanolone hemipimelate, inhibits tonic NMDAR currents without inhibiting the NMDAR component of the EPSC and shows neuroprotective activity in vivo without inducing psychomimetic side effects. These results suggest steroids may have a clinical advantage over other known classes of NMDAR inhibitors.

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences 166 10 Prague 2 Czech Republic and

Institute of Organic Chemistry and Biochemistry Czech Academy of Sciences 166 10 Prague 2 Czech Republic and Faculty of Mathematics and Physics Charles University Prague 121 16 Prague 2 Czech Republic

Institute of Physiology Czech Academy of Sciences 142 20 Prague 4 Czech Republic

Zobrazit více v PubMed

Ahlrichs R, Bar M, Haser M, Horn H, Kolmel C. Electronic-structure calculations on workstation computers–the program system turbomole. Chemical Physics Letters. 1989;162:165–169. doi: 10.1016/0009-2614(89)85118-8. DOI

Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA. Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci U S A. 2001;98:10037–10041. doi: 10.1073/pnas.181342398. PubMed DOI PMC

Barratt E, Bronowska A, Vondrásek J, Cerný J, Bingham R, Phillips S, Homans SW. Thermodynamic penalty arising from burial of a ligand polar group within a hydrophobic pocket of a protein receptor. J Mol Biol. 2006;362:994–1003. doi: 10.1016/j.jmb.2006.07.067. PubMed DOI

Bayly CI, Cieplak P, Cornell WD, Kollman PA. A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges–the resp model. J Phys Chem. 1993;97:10269–10280. doi: 10.1021/j100142a004. DOI

Beck C, Wollmuth LP, Seeburg PH, Sakmann B, Kuner T. NMDAR channel segments forming the extracellular vestibule inferred from the accessibility of substituted cysteines. Neuron. 1999;22:559–570. doi: 10.1016/S0896-6273(00)80710-2. PubMed DOI

Blanpied TA, Boeckman FA, Aizenman E, Johnson JW. Trapping channel block of NMDA-activated responses by amantadine and memantine. J Neurophysiol. 1997;77:309–323. PubMed

Borovska J, Vyklicky V, Stastna E, Kapras V, Slavikova B, Horak M, Chodounska H, Vyklicky L., Jr Access of inhibitory neurosteroids to the NMDA receptor. Br J Pharmacol. 2012;166:1069–1083. doi: 10.1111/j.1476-5381.2011.01816.x. PubMed DOI PMC

Bubser M, Keseberg U, Notz PK, Schmidt WJ. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats. Eur J Pharmacol. 1992;229:75–82. doi: 10.1016/0014-2999(92)90288-F. PubMed DOI

Burgalossi A, Jung S, Man KN, Nair R, Jockusch WJ, Wojcik SM, Brose N, Rhee JS. Analysis of neurotransmitter release mechanisms by photolysis of caged Ca2+ in an autaptic neuron culture system. Nat Protoc. 2012;7:1351–1365. doi: 10.1038/nprot.2012.074. PubMed DOI

Cavelier P, Hamann M, Rossi D, Mobbs P, Attwell D. Tonic excitation and inhibition of neurons: ambient transmitter sources and computational consequences. Prog Biophys Mol Biol. 2005;87:3–16. doi: 10.1016/j.pbiomolbio.2004.06.001. PubMed DOI PMC

Chen HS, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA. Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci. 1992;12:4427–4436. PubMed PMC

Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci. 1987;7:369–379. PubMed PMC

Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci. 1990;13:171–182. doi: 10.1146/annurev.ne.13.030190.001131. PubMed DOI

Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL. The time course of glutamate in the synaptic cleft. Science. 1992;258:1498–1501. doi: 10.1126/science.1359647. PubMed DOI

Dix S, Gilmour G, Potts S, Smith JW, Tricklebank M. A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists. Psychopharmacology. 2010;212:227–242. doi: 10.1007/s00213-010-1945-1. PubMed DOI

Emnett CM, Eisenman LN, Taylor AM, Izumi Y, Zorumski CF, Mennerick S. Indistinguishable synaptic pharmacodynamics of the N-methyl-D-aspartate receptor channel blockers memantine and ketamine. Mol Pharmacol. 2013;84:935–947. doi: 10.1124/mol.113.089334. PubMed DOI PMC

Faucher F, Cantin L, Luu-The V, Labrie F, Breton R. The crystal structure of human Delta4–3-ketosteroid 5beta-reductase defines the functional role of the residues of the catalytic tetrad in the steroid double bond reduction mechanism. Biochemistry. 2008;47:8261–8270. doi: 10.1021/bi800572s. PubMed DOI

Grimme S, Antony J, Ehrlich S, Krieg H. A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. J Chem Phys. 2010;132:154104. doi: 10.1063/1.3382344. PubMed DOI

Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci. 2010;11:682–696. doi: 10.1038/nrn2911. PubMed DOI PMC

Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci. 2002;5:405–414. PubMed

Herman MA, Jahr CE. Extracellular glutamate concentration in hippocampal slice. J Neurosci. 2007;27:9736–9741. doi: 10.1523/JNEUROSCI.3009-07.2007. PubMed DOI PMC

Huganir RL, Nicoll RA. AMPARs and synaptic plasticity: the last 25 years. Neuron. 2013;80:704–717. doi: 10.1016/j.neuron.2013.10.025. PubMed DOI PMC

Jurecka P, Cerný J, Hobza P, Salahub DR. Density functional theory augmented with an empirical dispersion term. Interaction energies and geometries of 80 noncovalent complexes compared with ab initio quantum mechanics calculations. J Comput Chem. 2007;28:555–569. doi: 10.1002/jcc.20570. PubMed DOI

Karakas E, Furukawa H. Crystal structure of a heterotetrameric NMDA receptor ion channel. Science. 2014;344:992–997. doi: 10.1126/science.1251915. PubMed DOI PMC

Klamt A, Schuurmann G. Cosmo–a new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient. J Chem Soc Perk T. 1993;2:799–805.

Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Jr, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry. 1994;51:199–214. doi: 10.1001/archpsyc.1994.03950030035004. PubMed DOI

Kudova E, Chodounska H, Slavikova B, Budesinsky M, Nekardova M, Vyklicky V, Krausova B, Svehla P, Vyklicky L. A new class of potent N-methyl-D-aspartate receptor inhibitors: sulfated neuroactive steroids with lipophilic D-ring modifications. J Med Chem. 2015;58:5950–5966. doi: 10.1021/acs.jmedchem.5b00570. PubMed DOI

Kussius CL, Kaur N, Popescu GK. Pregnanolone sulfate promotes desensitization of activated NMDA receptors. J Neurosci. 2009;29:6819–6827. doi: 10.1523/JNEUROSCI.0281-09.2009. PubMed DOI PMC

Lapchak PA. The neuroactive steroid 3-alpha-ol-5-beta-pregnan-20-one hemisuccinate, a selective NMDA receptor antagonist improves behavioral performance following spinal cord ischemia. Brain Res. 2004;997:152–158. doi: 10.1016/j.brainres.2003.10.047. PubMed DOI

Lapchak PA. 3alpha-OL-5-beta-pregnan-20-one hemisuccinate, a steroidal low-affinity NMDA receptor antagonist improves clinical rating scores in a rabbit multiple infarct ischemia model: synergism with tissue plasminogen activator. Exp Neurol. 2006;197:531–537. doi: 10.1016/j.expneurol.2005.10.025. PubMed DOI

Lee CH, Lü W, Michel JC, Goehring A, Du J, Song X, Gouaux E. NMDA receptor structures reveal subunit arrangement and pore architecture. Nature. 2014;511:191–197. doi: 10.1038/nature13548. PubMed DOI PMC

Léveillé F, El Gaamouch F, Gouix E, Lecocq M, Lobner D, Nicole O, Buisson A. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J. 2008;22:4258–4271. doi: 10.1096/fj.08-107268. PubMed DOI

Lipton SA. Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 1993;16:527–532. doi: 10.1016/0166-2236(93)90198-U. PubMed DOI

Lynch MA. Long-term potentiation and memory. Physiol Rev. 2004;84:87–136. doi: 10.1152/physrev.00014.2003. PubMed DOI

MacNevin CJ, Atif F, Sayeed I, Stein DG, Liotta DC. Development and screening of water-soluble analogs of progesterone and allopregnanolone in models of brain injury. J Med Chem. 2009;52:6012–6023. doi: 10.1021/jm900712n. PubMed DOI

Mameli M, Carta M, Partridge LD, Valenzuela CF. Neurosteroid-induced plasticity of immature synapses via retrograde modulation of presynaptic NMDA receptors. J Neurosci. 2005;25:2285–2294. doi: 10.1523/JNEUROSCI.3877-04.2005. PubMed DOI PMC

Manahan-Vaughan D, von Haebler D, Winter C, Juckel G, Heinemann U. A single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats. Hippocampus. 2008;18:125–134. doi: 10.1002/hipo.20367. PubMed DOI

McDonald JW, Silverstein FS, Cardona D, Hudson C, Chen R, Johnston MV. Systemic administration of MK-801 protects against N-methyl-D-aspartate- and quisqualate-mediated neurotoxicity in perinatal rats. Neuroscience. 1990;36:589–599. doi: 10.1016/0306-4522(90)90002-L. PubMed DOI

Meyer DA, Carta M, Partridge LD, Covey DF, Valenzuela CF. Neurosteroids enhance spontaneous glutamate release in hippocampal neurons. J Biol Chem. 2002;277:28725–28732. doi: 10.1074/jbc.M202592200. PubMed DOI

Micale V, Kucerova J, Sulcova A. Leading compounds for the validation of animal models of psychopathology. Cell Tissue Res. 2013;354:309–330. doi: 10.1007/s00441-013-1692-9. PubMed DOI

Mikulecká A, Subrt M, Stuchlík A, Kubová H. Consequences of early postnatal benzodiazepines exposure in rats. I. Cognitive-like behavior. Front Behav Neurosci. 2014;8:101. PubMed PMC

Newcomer JW, Krystal JH. NMDA receptor regulation of memory and behavior in humans. Hippocampus. 2001;11:529–542. PubMed

Olney JW. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science. 1969;164:719–721. doi: 10.1126/science.164.3880.719. PubMed DOI

Papadia S, Soriano FX, Léveillé F, Martel MA, Dakin KA, Hansen HH, Kaindl A, Sifringer M, Fowler J, Stefovska V, McKenzie G, Craigon M, Corriveau R, Ghazal P, Horsburgh K, Yankner BA, Wyllie DJ, Ikonomidou C, Hardingham GE. Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses. Nat Neurosci. 2008;11:476–487. doi: 10.1038/nn2071. PubMed DOI PMC

Parada-Turska J, Turski WA. Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology. 1990;29:1111–1116. doi: 10.1016/0028-3908(90)90034-O. PubMed DOI

Parsons MP, Raymond LA. Extrasynaptic NMDA receptor involvement in central nervous system disorders. Neuron. 2014;82:279–293. doi: 10.1016/j.neuron.2014.03.030. PubMed DOI

Petralia RS. Distribution of extrasynaptic NMDA receptors on neurons. ScientificWorldJournal. 2012;2012:267120. doi: 10.1100/2012/267120. PubMed DOI PMC

Petrovic M, Sedlacek M, Horak M, Chodounska H, Vyklický L., Jr 20-oxo-5beta-pregnan-3alpha-yl sulfate is a use-dependent NMDA receptor inhibitor. J Neurosci. 2005;25:8439–8450. doi: 10.1523/JNEUROSCI.1407-05.2005. PubMed DOI PMC

Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera–a visualization system for exploratory research and analysis. J Comput Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084. PubMed DOI

Rambousek L, Bubenikova-Valesova V, Kacer P, Syslova K, Kenney J, Holubova K, Najmanova V, Zach P, Svoboda J, Stuchlík A, Chodounska H, Kapras V, Adamusova E, Borovska J, Vyklicky L, Vales K. Cellular and behavioural effects of a new steroidal inhibitor of the N-methyl-D-aspartate receptor 3alpha5beta-pregnanolone glutamate. Neuropharmacology. 2011;61:61–68. doi: 10.1016/j.neuropharm.2011.02.018. PubMed DOI

Rogawski MA. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci. 1993;14:325–331. doi: 10.1016/0165-6147(93)90005-5. PubMed DOI

Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev. 2003;9:275–308. PubMed PMC

Sah P, Hestrin S, Nicoll RA. Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science. 1989;246:815–818. doi: 10.1126/science.2573153. PubMed DOI

Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234:779–815. doi: 10.1006/jmbi.1993.1626. PubMed DOI

Salomon-Ferrer R, Case DA, Walker RC. An overview of the Amber biomolecular simulation package. WIREs Comput Mol Sci. 2013;3:198–210. doi: 10.1002/wcms.1121. DOI

Sanner MF. Python: a programming language for software integration and development. Journal of molecular graphics and modelling. 1999;17:57–61. PubMed

Sobolevskii AI, Khodorov BI. Blocker studies of the functional architecture of the NMDA receptor channel. Neurosci Behav Physiol. 2002;32:157–171. doi: 10.1023/A:1013927409034. PubMed DOI

Sobolevsky AI, Beck C, Wollmuth LP. Molecular rearrangements of the extracellular vestibule in NMDAR channels during gating. Neuron. 2002;33:75–85. doi: 10.1016/S0896-6273(01)00560-8. PubMed DOI

Sobolevsky AI, Rosconi MP, Gouaux E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature. 2009;462:745–756. doi: 10.1038/nature08624. PubMed DOI PMC

Stastna E, Chodounska H, Pouzar V, Kapras V, Borovska J, Cais O, Vyklicky L., Jr Synthesis of C3, C5, and C7 pregnane derivatives and their effect on NMDA receptor responses in cultured rat hippocampal neurons. Steroids. 2009;74:256–263. doi: 10.1016/j.steroids.2008.11.011. PubMed DOI

Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 2010;62:405–496. doi: 10.1124/pr.109.002451. PubMed DOI PMC

Vyklicky V, Korinek M, Smejkalova T, Balik A, Krausova B, Kaniakova M, Lichnerova K, Cerný J, Krusek J, Dittert I, Horak M, Vyklicky L. Structure, function, and pharmacology of NMDA receptor channels. Physiol Res. 2014;63:S191–S203. PubMed

Vyklicky V, Krausova B, Cerný J, Balik A, Zapotocky M, Novotny M, Lichnerova K, Smejkalova T, Kaniakova M, Korinek M, Petrovic M, Kacer P, Horak M, Chodounska H, Vyklicky L. Block of NMDA receptor channels by endogenous neurosteroids: implications for the agonist induced conformational states of the channel vestibule. Sci Rep. 2015;5:10935. doi: 10.1038/srep10935. PubMed DOI PMC

Wahl F, Obrenovitch TP, Hardy AM, Plotkine M, Boulu R, Symon L. Extracellular glutamate during focal cerebral ischaemia in rats: time course and calcium dependency. J Neurochem. 1994;63:1003–1011. PubMed

Wang S, Lees GJ, Rosengren LE, Karlsson JE, Stigbrand T, Hamberger A, Haglid KG. The effect of an N-methyl-D-aspartate lesion in the hippocampus on glial and neuronal marker proteins. Brain Res. 1991;541:334–341. doi: 10.1016/0006-8993(91)91034-X. PubMed DOI

Weaver CE, Jr, Marek P, Park-Chung M, Tam SW, Farb DH. Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A. 1997;94:10450–10454. doi: 10.1073/pnas.94.19.10450. PubMed DOI PMC

Wroge CM, Hogins J, Eisenman L, Mennerick S. Synaptic NMDA receptors mediate hypoxic excitotoxic death. J Neurosci. 2012;32:6732–6742. doi: 10.1523/JNEUROSCI.6371-11.2012. PubMed DOI PMC

Xia P, Chen HS, Zhang D, Lipton SA. Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses. J Neurosci. 2010;30:11246–11250. doi: 10.1523/JNEUROSCI.2488-10.2010. PubMed DOI PMC

Young JW, Zhou X, Geyer MA. Animal models of schizophrenia. Curr Top Behav Neurosci. 2010;4:391–433. doi: 10.1007/7854_2010_62. PubMed DOI

Zamudio-Bulcock PA, Valenzuela CF. Pregnenolone sulfate increases glutamate release at neonatal climbing fiber-to-Purkinje cell synapses. Neuroscience. 2011;175:24–36. doi: 10.1016/j.neuroscience.2010.11.063. PubMed DOI PMC

Disease-Associated Variants in GRIN1, GRIN2A and GRIN2B genes: Insights into NMDA Receptor Structure, Function, and Pathophysiology

Corticosteroids as Selective and Effective Modulators of Glycine Receptors

Effects of Pregnanolone Glutamate and Its Metabolites on GABAA and NMDA Receptors and Zebrafish Behavior

Novel neurosteroid pregnanolone pyroglutamate suppresses neurotoxicity syndrome induced by tetramethylenedisulfotetramine but is ineffective in a rodent model of infantile spasms

Endogenous neurosteroids pregnanolone and pregnanolone sulfate potentiate presynaptic glutamate release through distinct mechanisms

Pitfalls of NMDA Receptor Modulation by Neuroactive Steroids. The Effect of Positive and Negative Modulation of NMDA Receptors in an Animal Model of Schizophrenia

Palmitoylation Controls NMDA Receptor Function and Steroid Sensitivity

Neurosteroids as Selective Inhibitors of Glycine Receptor Activity: Structure-Activity Relationship Study on Endogenous Androstanes and Androstenes

Strong Inhibitory Effect, Low Cytotoxicity and High Plasma Stability of Steroidal Inhibitors of N-Methyl-D-Aspartate Receptors With C-3 Amide Structural Motif

Zobrazit více v PubMed

PDB
3CAV